| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vaccinex Inc (NASDAQ: VCNX)
VCNX Technical Analysis
4
| As on 1st Apr 2025 VCNX STOCK Price closed @ 0.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.68 & Sell for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VCNXSTOCK Price
| Open | 0.76 | Change | Price | % |
| High | 0.76 | 1 Day | -0.28 | -28.57 |
| Low | 0.70 | 1 Week | 0.08 | 12.90 |
| Close | 0.70 | 1 Month | -0.45 | -39.13 |
| Volume | 1709 | 1 Year | 0.48 | 218.18 |
| 52 Week High 8.85 | 52 Week Low 0.11 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| RSLS | 1.59 | 341.67% |
| NVDA | 110.15 | 1.63% |
| TSLA | 268.46 | 3.59% |
| LMDX | 0.02 | 0.00% |
| LCID | 2.53 | 4.55% |
| AKTS | 0.04 | 0.00% |
| LILM | 0.05 | 0.00% |
| PONO | 1.72 | 2.38% |
| AAL | 10.30 | -2.37% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VCNX Daily Charts |
VCNX Intraday Charts |
Whats New @ Bazaartrend |
VCNX Free Analysis |
|
|
VCNX Important Levels Intraday
| RESISTANCE | 0.82 |
| RESISTANCE | 0.78 |
| RESISTANCE | 0.76 |
| RESISTANCE | 0.73 |
| SUPPORT | 0.67 |
| SUPPORT | 0.64 |
| SUPPORT | 0.62 |
| SUPPORT | 0.58 |
VCNX Forecast April 2025
| 4th UP Forecast | 4.42 |
| 3rd UP Forecast | 3.23 |
| 2nd UP Forecast | 2.49 |
| 1st UP Forecast | 1.75 |
| 1st DOWN Forecast | -0.35 |
| 2nd DOWN Forecast | -1.09 |
| 3rd DOWN Forecast | -1.83 |
| 4th DOWN Forecast | -3.02 |
VCNX Weekly Forecast
| 4th UP Forecast | 0.80 |
| 3rd UP Forecast | 0.77 |
| 2nd UP Forecast | 0.75 |
| 1st UP Forecast | 0.73 |
| 1st DOWN Forecast | 0.67 |
| 2nd DOWN Forecast | 0.65 |
| 3rd DOWN Forecast | 0.63 |
| 4th DOWN Forecast | 0.60 |
VCNX Forecast2025
| 4th UP Forecast | 20.16 |
| 3rd UP Forecast | 13.92 |
| 2nd UP Forecast | 10.06 |
| 1st UP Forecast | 6.2 |
| 1st DOWN Forecast | -4.8 |
| 2nd DOWN Forecast | -8.66 |
| 3rd DOWN Forecast | -12.52 |
| 4th DOWN Forecast | -18.76 |
Vaccinex Inc ( NASDAQ USA Symbol : VCNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VCNX Business Profile
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that is in Phase 1 and 2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders; and VX25, a bi-specific molecule based on natural killer T (NKT) vaccine platform for the therapeutic application of NKT cell stimulation for cancer immunotherapy. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Address: 1895 Mount Hope Avenue, Rochester, NY, United States, 14620
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service